Janux Shares Are Trading Higher After It Announced Doses Selected for Its Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose.
Janux Shares Are Trading Higher After It Announced Doses Selected for Its Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose.
Janux股票上涨，因其宣布选定用于第10亿扩展试验的剂量，支持观察到的第1a剂量的鼓舞人心的疗效和安全性概况。
Janux Shares Are Trading Higher After It Announced Doses Selected for Its Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose.
Janux股票在宣布为其10亿扩展试验选择的剂量后交易上涨，支持这一选择的有利疗效和安全性特点在1a期剂量中得到了观察。
热门讨论
中概股财报季火热：惊喜盈利能否延续涨势？
1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？
Moomoo News Global
03/04 23:26
中国两会：会议前后股票价格走势的主要要点